| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3979000 | Bulletin du Cancer | 2012 | 8 Pages |
Abstract
FDG-PET is widely used for the diagnosis, the staging and the search for recurrence of many tumors. However, there are currently no recommendations for its use in endometrial cancer. This article is an update of the literature data to enable everyone to form an opinion on the subject. Future prospects are considered.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hélène Kolesnikov-Gauthier, Philippe Carpentier,